Questions Persist About How Pfizer’s US Agreement Lowers Prices

 
• By Jessica Merrill
  
Pfizer CEO Albert Bourla reached a drug pricing deal with the White House that includes more domestic drug production and a tariff exemption. (Shutterstock)

More from Pricing Debate

More from United States